SCHEMBL18801366

SCHEMBL18801366

COC(=O)c1c(CSc2ccccc2)cccc1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
HDAC1 Q13547 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
KDM4E B2RXH2 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
HSP90AA1 P07900 1/20 0.45
HPGD P15428 2/20 0.44
TAAR1 Q96RJ0 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18801309 0.89 CA12 (0.57) SMN1; SMN2NPC1RAB9AL3MBTL1CA12
SCHEMBL18801490 0.85 SMN1; SMN2 (0.44) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL26746820 0.84 CA12 (0.57) SMN1; SMN2NPC1RAB9AL3MBTL1KDM4E
SCHEMBL18801347 0.80 L3MBTL1 (0.48) SMN1; SMN2NPC1RAB9AL3MBTL1KDM4E
SCHEMBL24169594 0.79 HDAC1 (0.59) SMN1; SMN2HDAC1HDAC6KDM4ECA12
SCHEMBL8611008 0.78 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9AL3MBTL1CA12
SCHEMBL10741549 0.78 HSP90AA1 (0.56) NPC1RAB9AHDAC1HDAC6CYP1A2
SCHEMBL12772497 0.78 L3MBTL1 (0.47) SMN1; SMN2NPC1RAB9AL3MBTL1KDM4E
SCHEMBL31123647 0.78 L3MBTL1 (0.58) SMN1; SMN2NPC1RAB9AL3MBTL1KDM4E
SCHEMBL11274332 0.78 L3MBTL1 (0.58) SMN1; SMN2NPC1RAB9AL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2486004-B1 SULPHONE COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY ZAFGEN INC (US) 2017-05-03 EP disclosed